Arkolith/Insider Trading/CSBR/Form 4

Mendelson Daniel Newman

DirectorCHAMPIONS ONCOLOGY, INC. (CSBR) · full profile →Form 4 · filed Jan 10, 2024
Net Buying
Open-Market Buys
$19K
Open-Market Sells
$0
Net Open-Market Flow
$19K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2024Buy(P)3K$6.25$19K193K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-001002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML